Reliq Health Technologies begins enrollment for pilot study with NHS England

13 November 2016 (Last Updated November 13th, 2016 18:30)

Canada-based Reliq Health Technologies has started patient enrollment at Imperial College Hospital London for a pilot study of its remote patient monitoring and care collaboration solution with the National Health Service (NHS) England.

Canada-based Reliq Health Technologies has started patient enrollment at Imperial College Hospital London for a pilot study of its remote patient monitoring and care collaboration solution with the National Health Service (NHS) England.

Reliq's digital health solution is designed to offer a fully automated virtual hospital ward in the patient's home, offering real-time tracking of patients' vital signs, medication adherence, and movements within the home.

The Health platform issues audible alerts and reminders directed to the patients to collect their vitals, take their medications and perform prescribed rehab or fitness activities, thereby promoting proactive self-care.

"The goal of this pilot is to demonstrate the value of Reliq Health's self-care solution in improving health outcomes and reducing the cost of care delivery for chronic disease patients after they are discharged home from hospital."

It also offers patient education materials to aid patients and their families in understanding and managing their chronic ailments.

Reliq Health CEO Dr Lisa Crossley said: "We are very excited to be launching our pilot with the NHS England and enrolling patients at our pilot site, Imperial College Hospital, London, UK.

"The goal of this pilot is to demonstrate the value of Reliq Health's self-care solution in improving health outcomes and reducing the cost of care delivery for chronic disease patients after they are discharged home from hospital.

“Our platform uses a combination of secure cloud-based software, voice technology, wearables and sensors to support patients and their loved ones in proactively managing their chronic conditions at home, reducing exacerbations and disease-related complications, decreasing healthcare costs and enhancing patient and family satisfaction".